Back
Aptevo Therapeutics Vs. Keros Therapeutics Industry Stock Comparison
Sell
14
APVO
Aptevo Therapeutics
Last Price:
4.10
Seasonality Move:
-34.13%
Sell
15
KROS
Keros Therapeutics
Last Price:
18.85
Seasonality Move:
14.46%
Sell
14
Aptevo Therapeutics (APVO)
is a Sell
Is Aptevo Therapeutics a Buy, Sell or Hold?
- The current Aptevo Therapeutics [APVO] share price is $4.09. The Score for APVO is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
- APVO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
15
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $18.83. The Score for KROS is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
- KROS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
APVO Stock Price Chart
What is Aptevo Therapeutics's stock price today?
-
The Aptevo Therapeutics share price today is $4.09
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APVO is experiencing selling pressure, which indicates risk of future bearish movement.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $18.83
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight selling pressure.
APVO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.69 | Sell |
Relative Strength Index (14 RSI): | 32.79 | Sell |
Chaikin Money Flow: | -796984 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.69 - 11.35) | Sell |
Bollinger Bands (100): | (7.17 - 13.87) | Sell |
KROS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -4.62 | Sell |
Relative Strength Index (14 RSI): | 22.69 | Sell |
Chaikin Money Flow: | -1326968 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (45.05 - 70.43) | Sell |
Bollinger Bands (100): | (46.62 - 63.56) | Sell |
APVO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.45 | Sell |
20-day SMA: | 9.45 | Sell |
50-day SMA: | 8.87 | Sell |
200-day SMA: | 38.37 | Sell |
8-day EMA: | 7.76 | Sell |
20-day EMA: | 8.92 | Sell |
50-day EMA: | 9.67 | Sell |
200-day EMA: | 177.43 | Sell |
KROS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 55.22 | Sell |
20-day SMA: | 55.96 | Sell |
50-day SMA: | 59.16 | Sell |
200-day SMA: | 55.11 | Sell |
8-day EMA: | 47 | Sell |
20-day EMA: | 54.67 | Sell |
50-day EMA: | 56.98 | Sell |
200-day EMA: | 53.66 | Sell |
Aptevo Therapeutics Earnings Growth & APVO Earnings Dates
- Analysts estimate an earnings increase this quarter of $11.84 per share, a decrease next quarter of $0.00 per share, an increase this year of $3,519.81 per share, and an increase next year of $64.38 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.03 per share, and an increase next year of $0.18 per share.
Aptevo Therapeutics Technical Analysis
Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Keros Therapeutics Technical Analysis
Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |